ticarcillin has been researched along with Gram-Negative Bacterial Infections in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 4 (17.39) | 2.80 |
| Authors | Studies |
|---|---|
| Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
| Eb, F; Guillon, H; Mammeri, H | 1 |
| Bocharova, YA; Chaplin, AV; Chebotar, IV; Fedorova, NI; Kondratenko, OV; Korostin, DO; Lyamin, AV; Mayansky, NA; Polikarpova, SV; Savinova, TA; Semykin, SY; Zhilina, SV | 1 |
| Alizadeh, SA; Anari, RK; Bakht, M; Javadi, A; Kelishomi, FZ; Nikkhahi, F; Rostamani, M | 1 |
| Chenouard, R; Eveillard, M; Kempf, M; Lemarié, C; Moriceau, C; Pailhoriès, H | 1 |
| Cao, Y; Chen, L; Chen, T; Liu, H; Wang, L; Yang, C; Zhou, W | 1 |
| Ferdinand, C; Young, DC; Zobell, JT | 1 |
| Arthur, C; Gossett, JG; Harik, N; Prodhan, P; Romero, JR; Tang, X | 1 |
| Sadikot, RT; Swenson, CE | 1 |
| Chong, SY; Chong, Y; Chung, HS; Hong, SG; Lee, K; Suh, Y | 1 |
| Chmura, A; Ciszek, M; Dobrzaniecka, K; Durlik, M; Kwiatkowski, A; Mlynarczyk, A; Mlynarczyk, G; Paczek, L; Sawicka-Grzelak, A; Szymanek-Majchrzak, K; Usarek, P | 1 |
| Abe, M; Araoka, H; Baba, M; Kimura, M; Okada, C; Yoneyama, A | 1 |
| Al-Hamad, A; Burnie, J; Upton, M | 1 |
| Amaya, RA; Edwards, MS | 1 |
| Friedlander, M; Rush, R | 1 |
| Chandy, M; Ebenezer, S; Jesudason, MV; Lalitha, MK | 1 |
| Abter, EI; Lutwick, LI; Mann, R; Torrey, MJ | 1 |
| Anderson, DE; Anderson, JD; Campbell, DM; Carroll, KC; Garrison, MW; Hollis, RJ; Malone, CL; Pfaller, MA | 1 |
| Hanaki, H; Nagayama, A; Nomura, S | 1 |
| Benes, J; Kabelková, M; Vacek, V | 1 |
| Downhour, NP; Krueger, TS; Nix, DE; Petersen, EA; Tangella, KV | 1 |
| Demonty, J; el Allaf, D; Rorive, G; Zgheib, A | 1 |
| Kua, LT; Limson, BM; Litam, P; Navarro-Almario, E; Que, E | 1 |
3 review(s) available for ticarcillin and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
Achromobacter respiratory infections.
Topics: Achromobacter; Age Factors; Anti-Bacterial Agents; Bronchiectasis; Cefoperazone; Cephalosporins; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Neoplasms; Penicillins; Piperacillin; Pneumonia, Bacterial; Respiratory Tract Infections; Risk Factors; Sex Factors; Ticarcillin; Virulence Factors | 2015 |
Agrobacterium radiobacter bacteremia in pediatric patients: case report and review.
Topics: Bacteremia; Catheterization, Central Venous; Child; Device Removal; Drug Therapy, Combination; Female; Follow-Up Studies; Gentamicins; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Opportunistic Infections; Rhizobium; Risk Assessment; Ticarcillin; Treatment Outcome | 2003 |
Intrathoracic infections with bacteraemia due to Eikenella corrodens as a complication of peritonsillar abscesses: report of a case and review of the literature.
Topics: Bacteremia; Eikenella corrodens; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Peritonsillar Abscess; Thoracic Diseases; Ticarcillin; Tomography, X-Ray Computed | 1992 |
1 trial(s) available for ticarcillin and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
Ceftazidime versus a combination of amikacin and ticarcillin in the treatment of severe infections.
Topics: Adult; Aged; Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Ticarcillin | 1988 |
19 other study(ies) available for ticarcillin and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
Topics: Amino Acid Sequence; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Capnocytophaga; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis | 2010 |
Characteristics of Stenotrophomonas maltophilia isolates from cystic fibrosis patients in Russia.
Topics: Anti-Bacterial Agents; Ceftazidime; Clavulanic Acid; Cystic Fibrosis; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Stenotrophomonas maltophilia; Ticarcillin | 2022 |
Evaluation of antibacterial activity of five biocides and the synergistic effect of biocide/EDTA combinations on biofilm-producing and non-producing Stenotrophomonas maltophilia strains isolated from clinical specimens in Iran.
Topics: Anti-Bacterial Agents; Biofilms; Ceftazidime; Chloramphenicol; Clavulanic Acid; Cross Infection; Disinfectants; Edetic Acid; Ethanol; Gram-Negative Bacterial Infections; Humans; Iran; Microbial Sensitivity Tests; Sodium Hypochlorite; Stenotrophomonas maltophilia; Ticarcillin | 2022 |
Stenotrophomonas maltophilia susceptibility to ceftazidime-avibactam combination versus ceftazidime alone.
Topics: Azabicyclo Compounds; Ceftazidime; Clavulanic Acids; Cystic Fibrosis; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Stenotrophomonas maltophilia; Ticarcillin | 2020 |
Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017.
Topics: Age Distribution; Anti-Bacterial Agents; Carbapenems; Ceftazidime; Child, Preschool; China; Clavulanic Acids; Comorbidity; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Immunosuppressive Agents; Infant; Intensive Care Units, Pediatric; Length of Stay; Male; Piperacillin, Tazobactam Drug Combination; Respiration, Artificial; Retrospective Studies; Risk Factors; Sex Distribution; Stenotrophomonas maltophilia; Surgical Procedures, Operative; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Continuous infusion meropenem and ticarcillin-clavulanate in pediatric cystic fibrosis patients.
Topics: Adolescent; Anti-Bacterial Agents; Clavulanic Acids; Cystic Fibrosis; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Meropenem; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rhodospirillaceae; Thienamycins; Ticarcillin | 2014 |
Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience.
Topics: Anti-Bacterial Agents; Clavulanic Acids; Female; Gram-Negative Bacterial Infections; Humans; Incidence; Infant; Infant, Newborn; Intensive Care Units; Levofloxacin; Male; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ceftazidime; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Membrane Transport Proteins; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Stenotrophomonas maltophilia; Ticarcillin; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
Drug Susceptibility Assessment in Stenotrophomonas Maltophilia Strains Isolated From the Blood of Organ Transplantation Recipients in a Warsaw Teaching Hospital During 2011 to 2014.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Levofloxacin; Microbial Sensitivity Tests; Organ Transplantation; Stenotrophomonas maltophilia; Ticarcillin; Transplant Recipients; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Clavulanic Acids; Drug Therapy, Combination; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Minocycline; Neoplasms; Stenotrophomonas maltophilia; Ticarcillin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
Enhancement of antibiotic susceptibility of Stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; ATP-Binding Cassette Transporters; Ciprofloxacin; Clavulanic Acids; Drug Synergism; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Rabbits; Stenotrophomonas maltophilia; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Alcaligenes xylosoxidans conjunctivitis.
Topics: Alcaligenes; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acids; Conjunctivitis, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Middle Aged; Ticarcillin | 2007 |
In vitro evaluation of newer beta-lactam antibiotics against gram negative bacilli isolated from neutropenic patients.
Topics: Anti-Bacterial Agents; Azlocillin; Clavulanic Acid; Clavulanic Acids; Drug Evaluation; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Neutropenia; Piperacillin; Pseudomonas aeruginosa; Sepsis; Ticarcillin | 1994 |
Cellulitis associated with bacteremia due to Flavobacterium meningosepticum.
Topics: Aged; Bacteremia; Cellulitis; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Male; Ticarcillin | 1993 |
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Gram-Negative Bacterial Infections; Humans; Mutation; Ticarcillin; Xanthomonas | 1996 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
[Clinical experience with Timentin].
Topics: Adult; beta-Lactamase Inhibitors; Clavulanic Acids; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Ticarcillin | 1997 |
Severe cellulitis/myositis caused by Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Aztreonam; Bone Marrow Transplantation; Cellulitis; Clavulanic Acid; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Monobactams; Muscle, Skeletal; Myositis; Penicillins; Risk Factors; Stenotrophomonas maltophilia; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |